Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 1;46(8):903-908.
doi: 10.1097/MAO.0000000000004572. Epub 2025 Jun 3.

Impact of Vestibular Schwannoma Management on Cochlear Implant Programming and Outcomes

Courtney Kolberg  1 , Jamie Bogle  1 , Melissa D DeJong  2 , Nicholas Deep  1 , Peter Weisskopf  1 , James R Dornhoffer  2 , Brian A Neff  2 , Colin L W Driscoll  2 , Matthew L Carlson  2 , Aniket A Saoji  2
Affiliations

Impact of Vestibular Schwannoma Management on Cochlear Implant Programming and Outcomes

Courtney Kolberg et al. Otol Neurotol. .

Abstract

Objectives: To compare electrical stimulation and speech perception in vestibular schwannoma (VS) patients across treatment modalities and standard cochlear implant (CI) patients.

Study design: Retrospective review.

Setting: Tertiary academic center.

Patients: Sixty-seven CI ears consisting of 23 standard CI controls and 44 VS patients with ipsilateral CI. VS patients were separated by treatment modality: 24 microsurgical resection, 15 radiation therapy, and 5 observation. Eleven VS patients with CI did not receive auditory sensation from electrical stimulation.

Interventions: VS microsurgical resection, radiation therapy, and observation.

Main outcome measures: Threshold (T-levels), comfort (C-levels), consonant-nucleus-consonant (CNC) word score, and AzBio sentence recognition scores.

Results: Patients who underwent microsurgical resection required significantly higher ( p < 0.001) T-levels and C-levels compared with the standard CI group. Stimulation levels in the VS radiation therapy and observation groups were higher but not significantly different compared with standard CI controls. Overall rate of CI nonstimulation across all VS patients was 25%: 38% for microsurgery and 13% for radiation. Average CNC score for microsurgery group was 18% compared with 44% for radiation, 55% for observation, and 68.5% for standard CI controls. CNC word and AzBio scores were significantly lower ( p < 0.001) for the microsurgery group compared with standard CI group.

Conclusions: Resection may negatively affect auditory nerve function, leading to higher stimulation levels, increased risk of nonstimulation, and poorer postoperative CI speech outcomes compared with observation or radiosurgery. When medically appropriate, nonsurgical VS management may be used to allow for optimization of CI programming and postoperative hearing outcomes.

Keywords: Acoustic neuroma; Charge levels; Cochlear implant; Cochlear implant programming; Cochlear implantation; Neurofibromatosis type 2; Sensorineural hearing loss; Vestibular schwannoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest and Source of Funding: J.R.D. receives research support from Advanced Bionics and Cochlear Ltd.; B.A.N. receives a consulting fee from Akuous, Inc.; C.L.W.D. receives research support from Envoy Medical; M.L.C. receives research support from Advanced Bionics, Cochlear Ltd., and Med-El; A.A.S. receives research support and a consulting fee from Advanced Bionics, Cochlear Ltd., and Envoy Medical. For remaining authors, none were declared. This study did not receive financial and material support.

References

    1. North HJ, Mawman D, O'Driscoll M, et al. Outcomes of cochlear implantation in patients with neurofibromatosis type 2. Cochlear Implants Int 2016;17:172–7.
    1. Wick CC, Butler MJ, Yeager LH, et al. Cochlear implant outcomes following vestibular schwannoma resection: Systematic review. Otol Neurotol 2020;41:1190–7.
    1. Deep NL, Patel EJ, Shapiro WH, et al. Cochlear implant outcomes in neurofibromatosis type 2: Implications for management. Otol Neurotol 2021;42:540–8.
    1. Patel EJ, Deep NL, Friedmann DR, et al. Cochlear implantation in sporadic vestibular schwannoma and other retrocochlear pathology: A case series. Otol Neurotol 2021;42:e425–32.
    1. Smith ME, Edmiston R, Trudel M, et al. Cochlear implantation in neurofibromatosis type 2: Experience from the UK neurofibromatosis type 2 service. Otol Neurotol 2022;43:538–46.